Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins
- PMID: 3190179
- PMCID: PMC175901
- DOI: 10.1128/AAC.32.10.1477
Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins
Abstract
A new carbacephem analog of cefaclor, LY163892, was examined along with four other cephalosporins for chemical stability and for antibacterial activity under a variety of susceptibility test conditions. LY163892 was found to be markedly more stable than cefaclor during storage at 4 and 35 degrees C in human serum, human urine, and various bacteriological media. Under these conditions, LY163892 demonstrated stability equal or superior to the stabilities of cephalexin, cephalothin, and cefuroxime. Broth and agar dilution susceptibility tests did not reveal significant differences in LY163892 activity in a variety of test media, although LY163892 MICs were somewhat higher in Mueller-Hinton chocolate agar or Trypticase soy broth (BBL Microbiology Systems, Cockeysville, Md.) than in other media. The activity of LY163892 against selected pathogens was only slightly influenced by the increased or decreased pH of the test medium, in a manner similar to that of the other cephalosporins tested. Thus, the carbacephem structure of LY163892 appears to represent a more stable cephalosporin than cefaclor, while retaining a similar antimicrobial spectrum.
Similar articles
-
Comparative in-vitro activity of a new oral carbacephem, LY163892.J Antimicrob Chemother. 1988 Oct;22(4):445-56. doi: 10.1093/jac/22.4.445. J Antimicrob Chemother. 1988. PMID: 3060458
-
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.J Clin Microbiol. 1988 Apr;26(4):770-3. doi: 10.1128/jcm.26.4.770-773.1988. J Clin Microbiol. 1988. PMID: 3259247 Free PMC article.
-
In vitro activities of LY163892, cefaclor, and cefuroxime.Antimicrob Agents Chemother. 1988 Jan;32(1):131-3. doi: 10.1128/AAC.32.1.131. Antimicrob Agents Chemother. 1988. PMID: 3348605 Free PMC article.
-
Antimicrobial activity of LY163892, an orally administered 1-carbacephem.J Antimicrob Chemother. 1988 Sep;22(3):315-20. doi: 10.1093/jac/22.3.315. J Antimicrob Chemother. 1988. PMID: 3182429
-
Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.Drugs. 1993 Feb;45(2):295-317. doi: 10.2165/00003495-199345020-00008. Drugs. 1993. PMID: 7681376 Review.
Cited by
-
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.Antimicrob Agents Chemother. 1990 Nov;34(11):2075-80. doi: 10.1128/AAC.34.11.2075. Antimicrob Agents Chemother. 1990. PMID: 2127342 Free PMC article.
-
Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis.Infection. 1992 Sep-Oct;20(5):301-8. doi: 10.1007/BF01710806. Infection. 1992. PMID: 1428189 Clinical Trial.
-
Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.Antimicrob Agents Chemother. 1990 Mar;34(3):467-9. doi: 10.1128/AAC.34.3.467. Antimicrob Agents Chemother. 1990. PMID: 2334158 Free PMC article.
-
Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.Antimicrob Agents Chemother. 1992 Nov;36(11):2569-72. doi: 10.1128/AAC.36.11.2569. Antimicrob Agents Chemother. 1992. PMID: 1489208 Free PMC article.
-
Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.Pharm Res. 1992 Feb;9(2):250-4. doi: 10.1023/a:1018949709797. Pharm Res. 1992. PMID: 1553350
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources